<?xml version="1.0" encoding="UTF-8"?>
<ref id="B20-vaccines-08-00098">
 <label>20.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Suzuki</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Takahashi</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Katano</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Ito</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Ito</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Harigae</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Ishii</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Sugamura</surname>
    <given-names>K.</given-names>
   </name>
  </person-group>
  <article-title>Induction of human humoral immune responses in a novel HLA-DR-expressing transgenic NOD/Shi-scid/Î³cnull mouse</article-title>
  <source>Int. Immunol.</source>
  <year>2012</year>
  <volume>24</volume>
  <fpage>243</fpage>
  <lpage>252</lpage>
  <pub-id pub-id-type="doi">10.1093/intimm/dxs045</pub-id>
  <pub-id pub-id-type="pmid">22402880</pub-id>
 </element-citation>
</ref>
